Globus Medical
Ownership
Ownership Structure
Who owns Globus Medical (GMED)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.5% of the shares are freely tradable; institutional investors hold 101.6%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 7.82 | 10,497,414 | +2.1 | 03/31/2026 |
| HHG PLC | 5.68 | 7,623,095 | +4.5 | 03/31/2026 |
| Vanguard Capital Management, LLC | 3.75 | 5,032,732 | +0.0 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 3.63 | 4,879,459 | +0.0 | 03/31/2026 |
| Amvescap Plc. | 3.22 | 4,316,654 | +11.1 | 03/31/2026 |
| State Street Corp | 2.67 | 3,590,372 | +3.7 | 03/31/2026 |
| OZ Management LLC | 2.28 | 3,058,000 | +1.9 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 2.96 | 3,968,793 | +0.0 | 08/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.69 | 3,606,830 | +0.3 | 07/31/2026 |
| Vanguard Small Cap Index | 1.94 | 2,602,046 | +0.2 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Davidar David D | Director | 507,675 | 37,618,718 $ | Jul 27, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Tobin James R | Director | Sell | 30,000 | 74.58 | 2,237,502 |
| Sep 15, 2026 | Tobin James R | Director | Other | 15,000 | 63.68 | 955,200 |
| Aug 18, 2026 | Zarrilli Stephen T | Director | Sell | 25,000 | 87.04 | 2,175,965 |
| Aug 18, 2026 | Zarrilli Stephen T | Director | Other | 25,000 | 53.27 | 1,331,750 |
| Jul 27, 2026 | Davidar David D | Director | Other | 2,500 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.